Remove Clinical Pharmacology Remove Laboratories Remove Protein Production Remove Virus
article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

The luncheon presentation will be given by Hans Gerstmans, Postdoctoral Researcher, Laboratory for Biomolecular Discovery & Engineering, KU Leuven, VIB, alongside Wai Long Tam, Head of Technology Watch at VIB, Technology Watch, VIB. The session ends with two presentations and two luncheon presentations.

article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Adams, on a first-in-human study of ELU001, a targeted c’dot drug conjugate, in subjects with folate receptor α (frα) overexpressing solid tumours, and Groothuis on the non-clinical pharmacology of the MET-targeting ADC BYON3521. He will cover the evaluation of safety and efficacy of antibody therapies in PBMC humanised mice.